OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of patients with fibrosing interstitial lung diseases
Lee E. Morrow, Daniel E. Hilleman, Mark A. Malesker
American Journal of Health-System Pharmacy (2021) Vol. 79, Iss. 3, pp. 129-139
Open Access | Times Cited: 9

Showing 9 citing articles:

Potential of resveratrol in the treatment of interstitial lung disease
Rongxiu Huo, Xinxiang Huang, Yanting Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12

Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
Nikitha Naomi Dsouza, Varun Alampady, Krishnaprasad Baby, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1167-1182
Open Access | Times Cited: 11

Burden of illness in patients with pulmonary hypertension due to interstitial lung disease: a real-world analysis
Gustavo A. Heresi, Bonnie B. Dean, Benjamin Wu, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Nintedanib and miR-29b co-loaded lipoplexes in idiopathic pulmonary fibrosis: formulation, characterization, and in vitro evaluation
Ceren Duraloglu, İpek Baysal, Samiye Yabanoğlu‐Çiftçi, et al.
Drug Development and Industrial Pharmacy (2024) Vol. 50, Iss. 7, pp. 671-686
Closed Access | Times Cited: 1

Lista de comprobación para la atención farmacéutica del paciente con enfermedad pulmonar intersticial (CheckEPID): un consenso basado en el método Delphi
Marta Calvin Lamas, Miguel Ángel Calleja Hernández, Emilio Monte‐Boquet, et al.
Farmacia Hospitalaria (2023) Vol. 47, Iss. 6, pp. 277-284
Open Access | Times Cited: 2

Are the gains from pulmonary rehabilitation the same in idiopathic pulmonary fibrosis and other interstitial lung diseases?
İpek Özmen, Elif Yıldırım, Meral Karakış, et al.
PubMed (2024) Vol. 41, Iss. 3, pp. e2024038-e2024038
Closed Access

Chronic Respiratory Disease: COPD, IPF
Raffaele Antonelli Incalzi, Filippo Luca Fimognari
Practical issues in geriatrics (2023), pp. 311-330
Closed Access | Times Cited: 1

Restoration of the morphofunctional state of rats lungs with experimental fibrosis through transplanted stem cells
A. Y. Mazurkevych, Yuliia Surtaieva
Agricultural science and practice (2023) Vol. 10, Iss. 1, pp. 12-23
Open Access

[Translated article] Checklist for the pharmaceutical care of patients with interstitial lung disease (CheckEPID): A Delphi-based consensus
M Calvín-Lamas, Miguel Ángel Calleja Hernández, Emilio Monte‐Boquet, et al.
Farmacia Hospitalaria (2023) Vol. 47, Iss. 6, pp. T277-T284
Open Access

Page 1

Scroll to top